A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease

NCT ID: NCT02620488

Last Updated: 2017-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study will assess the effects of a brief laboratory-based guided imagery procedure on responses to pain in patients with sickle cell disease (SCD) and healthy controls.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sickle Cell Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sickle Cell Disease

Brief guided imagery session with a trained clinician focused on relaxation and pleasant imagery.

Group Type EXPERIMENTAL

Guided Imagery

Intervention Type BEHAVIORAL

Brief guided imagery session with a trained clinician focused on relaxation and pleasant imagery.

Healthy Control

Brief guided imagery session with a trained clinician focused on relaxation and pleasant imagery.

Group Type ACTIVE_COMPARATOR

Guided Imagery

Intervention Type BEHAVIORAL

Brief guided imagery session with a trained clinician focused on relaxation and pleasant imagery.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Guided Imagery

Brief guided imagery session with a trained clinician focused on relaxation and pleasant imagery.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Healthy control or with a diagnosis of sickle cell disease
2. Age 13 or older
3. African-American
4. Subject is able to provide informed signed consent
5. Subject is able to follow instructions

Exclusion Criteria

1. Any known acute or chronic illness that in the judgment of the investigator, may compromise subject safety or data integrity
2. Neurologic disorders affecting sensation
3. Skin abnormality/abrasion over sites of stimulus
4. Under 13 years of age
5. Unable to follow instructions
Minimum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital Los Angeles

OTHER

Sponsor Role collaborator

University of California, Los Angeles

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lonnie Zeltzer

Distinguished Professor of Pediatrics, Anesthesiology, Psychiatry and Biobehavioral Sciences

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lonnie K Zeltzer, MD

Role: PRINCIPAL_INVESTIGATOR

UCLA Pediatric Pain and Palliative Care Program

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of California, Los Angeles

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

15-000420

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sickle Cell Disease (SCD) Bone Pain Study
NCT05283148 ACTIVE_NOT_RECRUITING NA
Fetal Hemoglobin Induction Treatment Metformin
NCT02981329 COMPLETED EARLY_PHASE1